GAS5 and neoplasm: Hence, downregulation of lncRNA GAS5 in the NK cells of liver cancer patients results in decreased natural cytotoxicity receptor NKp46 levels, a decline in INF-γ release and, eventually, in a reduction in NK cell cytotoxicity and CD107+ levels, thus facilitating tumor immune escape [79].